Serious lymphocytic leukemia (CLL) is usually a lymphoid malignancy characterised through the proliferation and accumulation of experienced CD5+ B cells while in the blood, bone marrow and lymphoid tissues. The diagnosis of CLL calls for the existence of ?5 x109/L mono - clonal B cells of common phenotype during the blood.See "Targeted therapies in